Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs

This publication has 59 references indexed in Scilit:

• Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA
  Veterinary Immunology and Immunopathology, 2006
• Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of .
  Vaccine, 2005
• Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran
  Vaccine, 2004
• Reduced immunogenicity of DNA vaccine plasmids in mixtures
  Gene Therapy, 2004
• A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum
  Veterinary Immunology and Immunopathology, 2003
• A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S o Gon alo do Amaranto, RN)
  Vaccine, 2000
• Immunization of animals: from DNA to the dinner plate
  Veterinary Immunology and Immunopathology, 1999
• Genetic Immunization with Glycoprotein 63 cDNA Results in a Helper T Cell Type 1 Immune Response and Protection in a Murine Model of Leishmaniasis
  Human Gene Therapy, 1998
• Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis
  Veterinary Immunology and Immunopathology, 1995
• The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis
  Parasite Immunology, 1987